PROCEPT BioRobotics Corporation
NASDAQ:PRCT
99.07 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 136.191 | 75.014 | 34.473 | 7.717 | 6.169 |
| Cost of Revenue
| 65.142 | 37.929 | 18.608 | 8.972 | 8.054 |
| Gross Profit
| 71.049 | 37.085 | 15.865 | -1.255 | -1.885 |
| Gross Profit Ratio
| 0.522 | 0.494 | 0.46 | -0.163 | -0.306 |
| Reseach & Development Expenses
| 48.446 | 28.981 | 18.993 | 16.275 | 13.147 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 131.773 | 88.828 | 51.036 | 30.272 | 28.518 |
| Other Expenses
| -0.176 | -0.203 | -0.154 | -0.025 | -0.046 |
| Operating Expenses
| 180.219 | 117.809 | 70.029 | 46.547 | 41.665 |
| Operating Income
| -109.17 | -80.724 | -54.164 | -47.802 | -43.55 |
| Operating Income Ratio
| -0.802 | -1.076 | -1.571 | -6.194 | -7.059 |
| Total Other Income Expenses Net
| 3.273 | -6.43 | -5.689 | -5.217 | 1.575 |
| Income Before Tax
| -105.897 | -87.154 | -59.853 | -53.019 | -41.975 |
| Income Before Tax Ratio
| -0.778 | -1.162 | -1.736 | -6.87 | -6.804 |
| Income Tax Expense
| 3.639 | 6.43 | 2.531 | 5.236 | 0.678 |
| Net Income
| -105.897 | -93.584 | -62.384 | -58.255 | -42.653 |
| Net Income Ratio
| -0.778 | -1.248 | -1.81 | -7.549 | -6.914 |
| EPS
| -2.24 | -2.11 | -1.43 | -1.35 | -0.99 |
| EPS Diluted
| -2.24 | -2.11 | -1.43 | -1.35 | -0.99 |
| EBITDA
| -105.363 | -78.713 | -54.043 | -44.783 | -40.953 |
| EBITDA Ratio
| -0.774 | -1.049 | -1.568 | -5.803 | -6.639 |